Try our corporate solution for free!
(212) 419-8286

U.S. spending on biosimilars by type 2014

This statistic displays the annual spending on biosimilars in the United States in 2014, by type. During this year, 8.6 billion U.S. dollars that were spent on insulins were to expire between 2015 and 2019. In 2009, the Biologics Price Competition and Innovation Act established a biosimilar pathway which has led to several applications and approvals.

Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

April 2015


United States

Survey time period


Supplementary notes

* Includes biological molecules in classes with current non-original biologics and upcomimg losses of exclusivity.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.